Our published immunoblotting studies indicated elevated APLP2 expression in human pancreatic cancer cells, and by immunohistochemistry we had demonstrated increased APLP2 presence in primary human pancreatic tumors and metastases relative to the normal pancreas [6,10]. The gene discussed is APLP2; the disease is pancreatic neoplasm.